Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Operating Leases (2019 - 2025)

Rockwell Medical's Operating Leases history spans 7 years, with the latest figure at $2.6 million for Q4 2025.

  • For Q4 2025, Operating Leases rose 53.56% year-over-year to $2.6 million; the TTM value through Dec 2025 reached $2.6 million, up 53.56%, while the annual FY2025 figure was $2.6 million, 53.56% up from the prior year.
  • Operating Leases reached $2.6 million in Q4 2025 per RMTI's latest filing, down from $3.0 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $7.4 million in Q1 2022 to a low of $1.4 million in Q4 2023.
  • Average Operating Leases over 5 years is $3.8 million, with a median of $3.6 million recorded in 2021.
  • Peak YoY movement for Operating Leases: surged 223.28% in 2021, then crashed 76.72% in 2023.
  • A 5-year view of Operating Leases shows it stood at $5.9 million in 2021, then tumbled by 56.16% to $2.6 million in 2022, then crashed by 44.48% to $1.4 million in 2023, then grew by 18.56% to $1.7 million in 2024, then skyrocketed by 53.56% to $2.6 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Operating Leases are $2.6 million (Q4 2025), $3.0 million (Q3 2025), and $3.5 million (Q2 2025).